Navigation Links
Sales of Energy-Boosting Diet Pills Skyrocket as the Economy Falters
Date:12/16/2008

SALT LAKE CITY, Dec. 16 /PRNewswire/ -- Can a high-energy diet pill really save your job? It seems that many people think so. Even as car manufacturers, clothing makers and other retailers are seeing a significant drop in sales due to the declining economy, diet pill maker Zoller(R) Laboratories is reporting dramatically increased sales of Zantrex-3(R), their high-energy diet pill.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081216/LA52707)

Zantrex-3's reputation has spread from college campuses (where students have been using it for years to increase cognitive performance, alertness and drive) to the workplace, where employees around the country are now using Zantrex on the job to stay alert, positive and productive.

"People are worried about the economy and, frankly, they're worried about whether they'll have a job next year," says Gina Daines, spokesperson for Zoller Labs. "They know that employers are being forced to make cutbacks and are paying close attention to employees' performance. And it may sound callous, but if you're an employer and you absolutely have to fire someone to stay in business, who are you going to choose? The guy nodding off at his desk, or the alert go-getter who actually gets things done? The choice seems obvious to me... and apparently to a lot of other people."

A recent article by Reuters pointed to the growing use of "brain-boosting drugs" in the workplace. Long a trend at colleges and universities, where students need help to cram for exams, older Americans are now turning to natural stimulants to help increase their mental capabilities and maintain their focus. And according to many physicians and psychologists, there's nothing wrong with that. In fact, boosting your ability to focus is really a "smart" thing to do. As reported in the December article, "We should welcome new methods of improving our brain function," wrote Henry Greely of Stanford Law School in California and Barbara Sahakian, a psychiatry professor from the University of Cambridge (England).

Zantrex-3 Sales Continue To Spike

"Since September we've seen a large spike in Zantrex sales while the supplement industry itself is facing declining sales and profits," says Ms. Daines. "Our figures show that both blue and white collar workers are turning to Zantrex for an instant kick and a sustained energy boost to power through the day and maintain optimum on-the-job performance."

Scientific evidence supports the energy-boosting and performance-enhancing capabilities of Zantrex-3's key ingredients. Several published clinical studies have shown that these ingredients can increase concentration, help users focus more clearly on a specific task and improve short-term memory.

Better yet, when you feel more energetic and more productive at work, your mood improves. "And let's face it," says Ms. Daines, "energetic, positive people are easier to hire and easier to keep. Enthusiasm and performance go a long way, especially in today's workplace."

If skyrocketing sales are any indication, it seems that millions of Americans, young and old, are convinced that taking Zantrex-3 to boost energy and improve performance is the really smart thing to do.

Web site: http://www.zantrex-3.com


'/>"/>
SOURCE Zoller Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mannatech Launches Phase One of New Sales and Training Tools
2. NBTY Announces Preliminary Unaudited Net Sales Results For August 2007
3. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
4. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
5. Resonant Medical Appoints New Vice President of Global Sales
6. portionpals(R) Sales Reach a Whopping 250,000 Units in 3 Months!
7. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
8. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
9. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
10. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
11. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: